Human fibroblasts and leukocytes produce interferons which may be distinguished by their antigenic and species specificity as well as by their molecular weight distributions. To elucidate the basis or these differences, we isolated mRNA from induced human fibroblasts and lymphoblastoid (Namalva) cells and studied the products of translation in Xenopus Iaevis oocytes. The mRNA from the respective cells yielded translation products, in oocytes, that were characteristic of the cells from which the mRNA was derived. We conclude that human cells contain at least two structural genes for interferon, coding for polypeptides differing in primary sequence. Fibroblasts synthesize a single species of interferon; Iymphoblastoid cells synthesize two species, the fibroblast and leukocyte types.
Interferons are proteins with characteristic antiviral activities and species specificities produced by various cells (1-4). Even within a species, several interferons may be produced. In fact, interferons made in cultures of human buffy coat cells (leukocyte interferon) or in human fibroblasts (fibroblast interferon) have a number of distinct properties. For example, antisera produced by immunization with fibroblast interferon fail to neutralize leukocyte interferon (5) (6) (7) . Leukocyte interferon exerts a high degree of activity in cell cultures of bovine or porcine origin, whereas fibroblast interferon is hardly active on these cells (8) . In addition, electrophoresis of fibroblast interferon in sodium dodecyl sulfate (NaDodSO4)/polyacrylamide gels yields a single peak of activity migrating equivalent to a molecular weight of approximately 20,000 (9, 10) . In contrast, leukocyte interferon produces two distinct peaks of activity with molecular weights of approximately 15,000 and 21,000 (10) (11) (12) . Also, leukocyte and fibroblast interferons exhibit differences in their stability towards various inactivating treatments (10, 11) and in their binding to lectin columns (13) .
Differences between human leukocyte and fibroblast interferons could originate in at least two ways. There may be two distinct structural genes for interferon, each coding for a protein with a unique primary sequence. Alternatively, if there were a single structural gene for interferon, differences might result from distinctive post-translational modifications carried out by lymphoid and nonlymphoid cells (e.g., glycosylation, proteolytic cleavages, etc.). In this case, the same polypeptide sequence would be synthesized but processed differently into the final active product in the different types of cells.
To distinguish between these alternatives, we isolated mRNA from human lymphoblasts and fibroblasts induced to produce their characteristic interferons and injected the mRNA into Xenopus laevis oocytes. Xenopus oocytes have been shown to translate various injected mRNAs and to carry out a number
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of posttranslational modifications including polypeptide cleavage (14, 15) , acetylation (16) , and glycosylation (17) . Because the secondary modifications produced by the oocytes would be expected to be the same for a single translational product, any differences observed in the interferons produced by the oocytes should represent differences in their mRNA sequences. EXPERIMENTAL PROCEDURE Chemicals. Poly(I)-poly(C) was obtained from P-L Biochemicals, Inc.; cycloheximide, from Upjohn; gentamicin, from Schering; flrmicroglobulin (125I-labeled), from Pharmacia; lysozyme, from Worthington Biochemical Corp. Bovine serum albumin, ovalbumin, chymotrypsinogen, and myoglobin were purchased from Sigma.
Preparation of Induced Human Fibroblasts. Human FS-4 fibroblasts were induced with poly(I)-poly(C) in the presence of cycloheximide as described (18, 19) .
Preparation of Namalva Cells Stimulated with Newcastle Disease Virus. A seed culture of the Namalva line of human lymphoblastoid cells (20) was kindly supplied by Charles
Buckler. The Namalva cells were grown in RPMI # 1640 medium supplemented with 10% fetal bovine serum, penicillin (100 units/ml), streptomycin (50 jig/ml), 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, pH 7 12 hr at 37°in the spinner bottles. At the end of the induction period, the cells were sedimented, frozen, and stored in a liquid nitrogen refrigerator. Approximately 10 g of packed cells was obtained from 5 liters of cell suspension. The supernatant, containing 500-1000 units of interferon activity per ml, was stored frozen at -20°.
Preparation of mRNA from Cells. Polyadenylylated mRNA was prepared from human fibroblasts and from Namalva cells as described (18, 21, 22) . The mRNA obtained after oligo(dT)-cellulose chromatography was used for most of the experiments in this study. Some mRNA from Namalva cells was further purified by centrifugation on an 11-ml linear 5-20% (wt/vol) sucrose gradient with a 1-ml 50% sucrose cushion in 0.02 M sodium acetate (pH 5.3). Centrifugation was performed at 37,000 rpm for 18 hr at 40 in an SW-40 rotor of the L2-65B Spinco ultracentrifuge. After centrifugation, the absorption of the gradient was recorded automatically at 260 nm (23 After -incubation, the oocytes were homogenized and centrifuged at 3000 X g at 5°for 10 min in the SS-34 rotor of a Sorvall RC-2B centrifuge. The supernatant was carefully removed and then stored at -70°until it was assayed for interferon activity.
Assay of Interferon Activity. Antiviral activity of interferon was assayed essentially as described (18) . Routine assays were performed with GM-258 human fibroblasts trisomic for chromosome 21 and highly reactive to interferon (26) . Although an interferon standard was included with each assay, all results are expressed as uncorrected titers. To evaluate species specificity, FS-7 fibroblasts and bovine (MDBK) cells were also used. Control leukocyte interferon was a gift of Kari Cantell. Antibody neutralization of interferon activity was carried out as described (5, 7, 27) with rabbit antiserum to -fibroblast interferon prepared in this laboratory and sheep antiserum to leukocyte interferon kindly supplied by Christian B. Anfinsen. NaDodSO4/Disc Gel Electrophoresis. The molecular weight of interferon was determined by discontinuous NaDodSO4/disc gel electrophoresis (28) . Samples were dissolved in a small volume of 62.5 mM Tris-HCl (pH 6.8) containing 3% (wt/vol) NaDodSO4 and 10% (wt/vol) glycerol. No reducing agent was added and the samples were not boiled prior to electrophoresis. The 12.5% polyacrylamide gels (0.6 X 11 cm) containing 0.1% NaDodSO4 were mechanically sliced and crushed (2 mm per fraction) with an automatic gel fractionator (Gilson Electronics). The protein was eluted from the crushed gel into 0.30 ml of 5 mM Tris-HCl buffer (pH 6.8) containing 0.004% NaDodSO4 by incubating at 370 overnight. From each fraction, 25 Al was assayed directly for interferon activity and 50 ,ul was assayed for radioactivity in a Triton X-100/toluene scintillation fluor for the presence of molecular weight markers: mineral oil-induced plasmacytoma (MOPC-315) immunoglobulin light (L315) and heavy (H315) chains labeled with 14C-tagged amino acids (21, 22) . H315 was determined to be 54,500 (29) and L315 to be 22,261 daltons (30) . Each entire gel fraction was assayed for 125I-labeled f2-microglobulin which was calculated to have a molecular weight of 11,800 (31) . Electrophoresis of unlabeled molecular weight standards was performed in duplicate gels simultaneously with the gel containing the interferon preparations.
RESULTS

Synthesis of Human Interferon by X. laevis Oocytes.
Poly(A)-containing mRNA from induced FS-4 fibroblasts was injected into X. laevis oocytes. Synthesis of human interferon as a function of time at three different mRNA concentrations is shown in Fig. 1A . At 7 and 39 ng of mRNA per oocyte, synthesis of interferon was linear for at least 6 hr. At longer incubation times, a plateau of interferon activity was reached. Interferon synthesis as a function of the amount of mRNA injected into oocytes indicated that the quantity of interferon produced was proportional to the mRNA injected up to about 20 ng per oocyte (Fig. 1B) . Apparently a plateau was reached at 40 ng per oocyte. Because previous reports (24, 25) suggested that X. laevis oocytes should be incubated at 180, we examined the effect of temperature on interferon synthesis (Fig. 1C) and found that 23°is the optimal temperature for synthesis of interferon.
Comparison of Interferons Synthesized by X. Iaevis Oocytes Injected with mRNA from Lymphoblasts and Fibroblasts. Poly(A)-containing mRNA, isolated from FS-4 human fibroblasts and human lymphoblastoid (Namalva) cells that had been induced to synthesize interferon, was injected into X. laevis oocytes. The mRNA from both cell types produced substantial amounts of human interferon (Table 1) ; 25 ng of fibroblast mRNA per oocyte produced 3584 units of interferon activity per ml, and 152 ng of Namalva mRNA per oocyte yielded 128 units/ml. Antigenic Specificity of the Interferons. Interferon synthesized when fibroblast mRNA was injected into oocytes was neutralized by antiserum to fibroblast interferon but not by antiserum to leukocyte interferon (Table 2 ). Interferon synthesized when Namalva mRNA was injected either was not neutralized or was only partially neutralized by either antiserum alone. A mixture of both antisera was required for complete neutralization. Interferons produced in intact fibroblast or Namalva cell cultures showed the same neutralization patterns as the corresponding oocyte products. A control demonstrated that interferon from primary leukocyte cultures was specifically neutralized by antileukocyte-interferon antiserum and not by antifibroblast-interferon antiserum. Thus, the oocyte products resembled the products of the cells from which the mRNA was derived.
The fact that complete neutralization of Namalva cellular interferon required a mixture of antileukocyte-interferon antiserum and antifibroblast-interferon antiserum suggested that Namalva interferon (as well as the oocyte product synthesized after injection with mRNA from Namalva cells) contained a mixture of leukocyte and fibroblast interferons. This conclusion was confirmed by separating the interferon components by affinity chromatography on a column of Sepharose 4B coupled with gamma-globulin specifically reactive with fibroblast interferon (5). Interferon with fibroblast antigenic specificity was completely retained by the column, and interferon that could be neutralized completely by antileukocyte-interferon antiserum was found in the void volume (results not shown).
Cellular Specificity of Interferon. A comparison of the antiviral action of the various interferon preparations on human and bovine cell lines is summarized in Table 3 . FS-4 interferon was several hundredfold (384-500) more active on human FS-7 cultures than on bovine cells (MDBK). A similar high ratio (FS-7/MDBK) of activities was seen with the interferon produced in oocytes after injection with FS-4 mRNA. In agreement with an earlier report (8) , leukocyte interferon exerted a much higher degree of activity on bovine cells than did fibroblast interferon. This is evident in the low FS-7/MDBK and GM-258/MDBK activity ratios compared to fibroblast interferon. Namalva interferon, as well as the corresponding oocyte product, resembled leukocyte interferon in this respect. This is the result expected by the presence of leukocyte interferon in these preparations. All of these human Interferons were more (Fig. 2) . Because the gels were run under slightly different conditions, the standard proteins and interferon did not migrate to the same fraction in each gel.
Analogously, a preparation of Namalva interferon and the corresponding oocyte product synthesized on a Namalva mRNA template were analyzed by NaDodSO4/polyacrylamide gel electrophoresis (Fig. 3) . Namalva interferon migrated faster than did fibroblast interferon; it exhibited broader peaks of activity possibly corresponding to a major peak of 16,000 daltons and a minor peak of 18,000 daltons. Some activity was even detectable corresponding to 21,000 daltons where fibroblast interferon would be expected. The oocyte product resulting from injection of Namalva mRNA exhibited a similar molecular weight distribution with the peak of activity corresponding to 16,000 daltons. DISCUSSION Recent studies have shown that mRNA extracted from cells actively producing interferon can direct interferon synthesis in some heterologous intact animal cells (32) (33) (34) or in cell-free systems (18, 35, 36) . In this study, we used X. Iaevis oocytes for the translation of human interferon mRNA isolated from two different cellular sources. The oocytes translate injected interferon mRNA with greater efficiency than do cell-free systems (18, 35) .
Interferon produced by the Namalva line of human lymphoblastoid cells was reported to closely resemble leukocyte interferon produced in primary cultures of buffy coat cells (37) . We found, however, that interferon produced in Namalva cells could not be completely neutralized by a monospecific antiserum against leukocyte interferon. A mixture of antileukocyte-interferon antiserum and antifibroblast-interferon antiserum was required for complete neutralization. We conclude that Namalva interferon is a mixture of two types of interferon, Biochemistry: Cavalied et al. Because interferon produced in oocytes with Namalva mRNA also required a mixture of the two anti-interferon antisera for complete neutralization, we conclude that the prep- (Table 3) . It is noteworthy that in each case with both the fibroblast and Namalva interferons the cellular and corresponding oocyte products had very similar-molecular weights. Thus, because both interferons are thought to contain substantial carbohydrate (38) , it is likely that glycosylation occurred in the oocyte. Studies of the translation of an immunoglobulin mRNA (MOPC-46B mRNA) injected into oocytes have shown that the oocytes can synthesize and glycosylate the immunoglobulin chain (17) . In contrast, however, our cell-free ascites extracts do not fully glycosylate de novo synthesized proteins (39) . Thus, the human interferon synthesized in cell-free extracts (18) was not fully glycosylated, yet it was active. It is thus likely that the intact carbohydrate moiety is not required for biological activity, a conclusion also suggested by Bose et al. (38) .
The present study indicates that human interferons produced in oocytes with mRNA preparations extracted from FS-4 fibroblasts or Namalva lymphoblastoid cells show the same characteristic molecular weights and antigenic properties as the products of the intact cells from which the mRNA was derived. These findings support the conclusions that the mRNAs are different and, therefore, that the amino acid sequences of the interferons synthesized on these mRNA templates must be different. Our work thus provides evidence for the existence of two human interferon genes, ifnLe and ifnF. Both of these genes are expressed in induced lymphoblastoid (Namalva) cells, but only one of these genes (ifnF) appears to function in the FS-4 fibroblasts.
Although the two interferons differ in amino acid sequence, they have similar, though not identical, biological activities. It is possible, therefore, that the portions of their structures conveying antiviral activity may be homologous. Because they differ markedly in antigenic specificity, it is not likely that such homologous regions would be extensive. Accordingly, it would not be surprising to discover relatively small peptides effectively simulating these regions and consequently interacting with the cell surface to generate potent antiviral activities.
